Inventor
Sukanta Kamila
Inventor
Dallas, TX, US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds71%
A61KPreparations for medical, dental or toiletry purposes14%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
PatentTitleYear
10,093,681Compounds and derivatives of 2H-pyrido (3,2-b)(1, 4) oxazin 3)4H)-ones as raf kinase and LRRK2 inhibitors20189,567,305'Quinoxaline compounds and derivatives'20179,493,452'Compounds and derivatives of 2H-pyrido (3,2-b)(1, 4) oxazin 3)4H)-ones as raf kinase and LRRK2 inhibitors'20169,309,208'Methods of making and using thioxothiazolidine and rhodanine derivatives as HIV-1 and JSP-1 inhibitors'20168,669,363'Quinoxaline compounds and derivatives'2014Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2014–2018Patents assigned to UNIV SOUTHERN METHODIST (5)· patent assignee history
2014–2016Patents assigned to ANKATI HARIBABU (2)· patent assignee history
2014–2016Patents assigned to BIEHL EDWARD R (2)· patent assignee history
2014–2016Patents assigned to KAMILA SUKANTA (2)· patent assignee history
2014–2017Based in Dallas, TX, US· patent location history
2016Patents assigned to UNIV JOHNS HOPKINS (1)· patent assignee history
2018Based in Coleraine, IE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV SOUTHERN METHODIST | 5 | 2014–2018 |
| ANKATI HARIBABU | 2 | 2014–2016 |
| BIEHL EDWARD R | 2 | 2014–2016 |
| KAMILA SUKANTAself | 2 | 2014–2016 |
| UNIV JOHNS HOPKINS | 1 | 2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Dallas, Texas, US | 4 | 2014–2017 |
| Coleraine, IE | 1 | 2018 |